Sustained response after rilzabrutinib discontinuation in multirefractory immune thrombocytopenia.
Saved in:
| Title: | Sustained response after rilzabrutinib discontinuation in multirefractory immune thrombocytopenia. |
|---|---|
| Authors: | González-López TJ; Department of Hematology, Hospital Universitario de Burgos, Burgos, Spain., Orza F; Pharmacy Service, Hospital Universitario de Burgos, Burgos, Spain., Cuesta-García A; Department of Hematology, Hospital General Sierrallana-Tres Mares, Torrelavega, Spain., Pérez-Gómez N; Research Unit, Fundación Burgos por la Investigación de la Salud, Hospital Universitario de Burgos, Burgos, Spain., Fedele JL; Department of Hematology, Hospital Privado Rosario, Rosario, Argentina., Provan D; Department of Haematology, Barts and The London School of Medicine, London, United Kingdom., Kuter DJ; Hematology Division, Massachusetts General Hospital, Harvard Medical School, Boston, MA. |
| Source: | Blood vessels, thrombosis & hemostasis [Blood Vessel Thromb Hemost] 2026 Apr 13; Vol. 3 (2), pp. 100167. Date of Electronic Publication: 2026 Apr 13 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Inc Country of Publication: United States NLM ID: 9918957761606676 Publication Model: eCollection Cited Medium: Internet ISSN: 2950-3272 (Electronic) Linking ISSN: 29503272 NLM ISO Abbreviation: Blood Vessel Thromb Hemost Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
